NYTIMES  |  Health

F.D.A. Faces Upset Over Denials of New Drugs

美国食品药品监督管理局因拒绝新药而面临不满

Megan and Ed Selser with their son, Ben, who is 2 and a half. He has Hunter syndrome, a genetic defect that eliminates an enzyme needed to break down sugar.

Megan and Ed Selser with their son, Ben, who is 2 and a half. He has Hunter syndrome, a genetic defect that eliminates an enzyme needed to break down sugar.

2026-03-05  1896  晦涩
字体

0:00
0:00

此音频仅限会员使用成为会员

The agency rejected the therapy last month, one in a series of denials over the last eight months that have dashed the hopes of desperate families. Though Ms. Selser’s son wasn’t a candidate for this particular gene therapy, she has been worried about other options awaiting an F.D.A. decision.

请登录后继续阅读完整文章

还没有账号?立即注册

成为会员后您将享受无限制的阅读体验,并可使用更多功能,了解更多


免责声明:本文来自网络公开资料,仅供学习交流,其观点和倾向不代表本站立场。